Genesco Files Investor Presentation
Genesco urges shareholders to protect the value of their investment by voting the BLUE proxy card today "FOR" all nine of the Company's highly qualified directors in connection with Genesco's Annual Meeting of Shareholders scheduled to be held on
Highlights from the presentation include:
Genesco's Compelling Execution, Including During the Pandemic
- During the pandemic, Genesco delivered strong performance, including record digital revenues, reduced operating expenses, increased liquidity, and significant sequential quarterly improvement in revenue and profit margins with increased cash flow in FY2021 vs. FY2020.
- Genesco's footwear focused strategy delivered strong results pre-pandemic and the Company delivered 11 consecutive quarters of total comparable sales growth between Q2 FY2018 and Q4 FY2020.
- Genesco is off to a strong start in FY2022, recently reporting an increase in revenue of 9% and an increase in adjusted operating income of 125% in Q1 FY2022 over the pre-pandemic period of Q1 FY2020 (+71% growth in GAAP OI vs. Q1 FY2020)1.
The Company's Strategy and Thoughtful Allocation of Capital Position Genesco to Continue Creating Greater Value
- Genesco's footwear focused strategy has provided a strong platform for growth and capital efficiency, and the Company is on track to deliver adjusted operating margin of 6% or more by FY2025.
- This strategy enables Genesco to leverage synergies across its platforms to enhance scale and profitability.
- Genesco's business is anchored upon a robust, direct-to-consumer model, which is driven by leading retail brands and a growing digital platform.
- The Board and management's prudent capital allocation focuses on reinvestment in the business, returning excess capital to shareholders, and maintaining balance sheet flexibility.
Genesco Has Assembled the Right Board and Management Team for Continued Success
- Genesco's Board is fresh, independent, and diverse, and each Director brings highly relevant skills and experiences that are essential to its footwear focused strategy and to delivering long-term, sustainable shareholder value.
- The Board decisively oversaw and implemented a strategic transformation to address changes in retail, the increasing importance of digital and resultant need for scale and system efficiencies, and has made deliberate changes to support near- and long-term value creation.
- Under Lead Independent Director
Matthew Diamond's leadership, the Board appointedMimi Vaughn as President and CEO inFebruary 2020 and Board Chair inJuly 2020 to help drive strategy execution and brought in additional key management team members aligned with Genesco's footwear focused strategy. - Genesco has added five new directors (representing a majority of the Board) since 2019 with specific skillsets required to oversee the footwear focused strategy, and four directors left the Board over that same period, resulting in an average director tenure of less than five years.
- The Compensation Committee of the Board executed a thoughtful, performance-aligned executive compensation program designed to directly incentivize shareholder value creation, of which Say-on-Pay advisory vote garnered an average of 95% shareholder support over the past five years.
- The Company recently formed an ESG subcommittee under the
Nominating and Governance Committee to provide oversight of its environmental, health and safety, diversity, equity and inclusion, corporate social responsibility, and corporate governance and sustainability initiatives.
Genesco Believes Legion's Baseless Campaign and Underqualified Nominees Would Introduce Significant Risk for Shareholders
- Genesco has taken every possible action to engage with Legion constructively, but at every turn Legion has refused to collaborate or share any business plans, strategic ideas, or how their nominees support a compelling vision for Genesco's future.
- Legion has demonstrated a fundamental lack of understanding of Genesco's business and of the skills and expertise necessary for Genesco's Board.
- Legion's nominees are underqualified and lack the principal footwear, public company CEO or CFO, substantial eCommerce, or public board experience to serve on Genesco's Board.
- Despite Genesco's majority-refreshed Board, Legion's campaign would result in 100% of the Board's independent directors turning over in less than a nine-month period. Consequently, the Board would have an average board tenure of only four months.
- Legion has not demonstrated that it is a long-term shareholder; during its 2018 campaign, Legion began selling its position after only four months and completely exited less than 16 months after settling for board seats.
Genesco strongly urges shareholders to vote the BLUE proxy card FOR ALL the Company's highly qualified and experienced director nominees. Shareholders are reminded that their vote is important, no matter how many or how few shares they own. Voting the WHITE proxy card, even in protest, will revoke any previous proxy submitted using the BLUE proxy card. Only the latest-dated proxy counts.
If shareholders have any questions or need help voting their BLUE proxy card, please contact:
Innisfree
1 (877) 825-8772
(toll-free from the
+1 (412) 232-3651
(from other locations)
About
Forward-Looking Statements
This release contains forward-looking statements, including those regarding the performance outlook for the Company and all other statements not addressing solely historical facts or present conditions. Forward- looking statements are usually identified by or are associated with such words as "intend," "expect," "believe," "should," "anticipate," "optimistic," "on track" and similar terminology. Actual results could vary materially from the expectations reflected in these statements. A number of factors could cause differences. These include adjustments to projections reflected in forward-looking statements, including those resulting from the effects of COVID-19 on the Company's business, including COVID-19 case spikes in locations in which the Company operates, the roll-out of COVID-19 vaccines and the public's acceptance of the vaccines, additional stores closures due to COVID-19, the timing of the re-opening of our stores, the timing of in-person back-to-work and back-to-school and sales with respect thereto, weakness in store and shopping mall traffic, restrictions on operations imposed by government entities and/or landlords, changes in public safety and health requirements, and limitations on the Company's ability to adequately staff and operate stores. Differences from expectations could also result from stores closures and effects on the business as a result of civil disturbances; the level and timing of promotional activity necessary to maintain inventories at appropriate levels; the imposition of tariffs on product imported by the Company or its vendors as well as the ability and costs to move production of products in response to tariffs; the Company's ability to obtain from suppliers products that are in-demand on a timely basis and effectively manage disruptions in product supply or distribution, including disruptions as a result of COVID-19; unfavorable trends in fuel costs, foreign exchange rates, foreign labor and material costs, and other factors affecting the cost of products; the effects of the British decision to exit the
Important Additional Information and Where to Find It
Genesco has filed a definitive proxy statement (the "Proxy Statement") and accompanying proxy card in connection with the solicitation of proxies for the 2021 annual meeting of Genesco shareholders (the "Annual Meeting"). INVESTORS AND SHAREHOLDERS ARE STRONGLY ENCOURAGED TO READ THE PROXY STATEMENT AND ACCOMPANYING PROXY CARD AND OTHER DOCUMENTS FILED WITH THE
Participants in the Solicitation
Genesco, its directors and certain of its executive officers may be deemed to be participants in the solicitation of proxies from Genesco shareholders in connection with the matters to be considered at the Annual Meeting. Information regarding the names of Genesco's directors and executive officers and certain other individuals and their respective interests in Genesco by security holdings or otherwise is set forth in the Annual Report on Form 10-K of Genesco for the fiscal year ended
1Adjusted operating income excludes fees related to the shareholder activist, retail store asset impairments and expenses related to the new headquarters building, net of tax effect in the first quarter of Fiscal 2022 (the "Excluded Items"). A reconciliation of operating income in accordance with
Adjusted Operating Income (Loss) by Segment |
||||||||
May 1, 2021 |
May 4, 2019 |
|||||||
Operating |
Asset Impair |
Adj Operating |
Operating |
Asset Impair |
Adj Operating |
|||
In Thousands |
Income (Loss) |
& Other Adj |
Income (Loss) |
Income (Loss) |
& Other Adj |
Income (Loss) |
||
|
$ 33,124 |
$ - |
$ 33,124 |
$ 18,976 |
$ - |
$ 18,976 |
||
|
(3,847) |
- |
(3,847) |
(5,428) |
- |
(5,428) |
||
|
(3,180) |
- |
(3,180) |
5,106 |
- |
5,106 |
||
Licensed Brands |
2,561 |
- |
2,561 |
429 |
- |
429 |
||
Goodwill Impairment |
- |
- |
- |
- |
- |
- |
||
Corporate and Other |
(13,131) |
3,267 |
(9,864) |
(9,999) |
(731) |
(10,730) |
||
Total Operating Income |
$ 15,527 |
$ 3,267 |
$ 18,794 |
$ 9,084 |
$ (731) |
$ 8,353 |
||
% of sales |
2.9% |
3.5% |
1.8% |
1.7% |
View original content:http://www.prnewswire.com/news-releases/genesco-files-investor-presentation-301318729.html
SOURCE
Claire S. McCall, cmccall@genesco.com, (615) 308-2483; Or Jared Levy / Danya Al-Qattan, Sard Verbinnen & Co, Genesco-SVC@sardverb.com; Investor Contacts: Tom George, tgeorge@genesco.com, (615) 367-7465; Or David Slater, dslater@genesco.com, (615) 367-7604